Outperform Recommendation Issued On CHRS By Oppenheimer
Oppenheimer analyst issues OUTPERFORM recommendation for CHRS on January 22, 2026 09:08PM ET. CHRS was trading at $1.59 at issue of the analyst recommendation.The overall analyst consensus : BUY.Current analyst...








